Dr. Reddy's Laboratories
RDY
#2051
Rank
C$13.82 B
Marketcap
C$16.61
Share price
3.69%
Change (1 day)
-16.10%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2026 (TTM): C$0.91 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are C$3.76 Billion. In 2025 the company made an earning of C$1.22 Billion a decrease over its 2024 earnings that were of C$1.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.91 B-25.76%
2025 C$1.22 B-2.73%
2024 C$1.26 B7.01%
2023 C$1.18 B32.93%
2022 C$0.88 B26.77%
2021 C$0.70 B31.44%
2020 C$0.53 B54.54%
2019 C$0.34 B-14.21%
2018 C$0.40 B26.41%
2017 C$0.31 B4.47%
2016 C$0.30 B-55.7%
2015 C$0.68 B1.83%
2014 C$0.67 B-3.78%
2013 C$0.70 B54.07%
2012 C$0.45 B-16.23%
2011 C$0.54 B56.66%
2010 C$0.34 B-235.36%
2009 -C$0.26 Billion-198.53%
2008 C$0.26 B30.77%
2007 C$0.19 B-14.61%
2006 C$0.23 B703.63%
2005 C$28.98 M649.45%
2004 C$3.86 M-95.68%
2003 C$89.44 M-14.86%
2002 C$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.21 B 2,278.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.90 B 1,495.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.77 B 1,053.88%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
C$14.08 B 1,408.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$3.19 B 242.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel